Search

Your search keyword '"Forconi, Francesco"' showing total 425 results

Search Constraints

Start Over You searched for: Author "Forconi, Francesco" Remove constraint Author: "Forconi, Francesco" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
425 results on '"Forconi, Francesco"'

Search Results

1. Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms

4. Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial

6. BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

7. Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial

8. The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.

9. High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL

11. Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia

12. KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodies.

14. Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

16. Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study

18. Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia

20. BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemia

21. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

23. IL-4 enhances expression and function of surface IgM in CLL cells

26. The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse model

27. DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features

30. CLL-638 Latest Results From an Ongoing Firstin-Human Phase 1a/B Study of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients With Relapsed/Refractory CLL and Other B-Cell Malignancies

31. Latest Results From an Ongoing First-in-Human Phase 1a/B Study of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients With Relapsed/Refractory CLL and Other B-Cell Malignancies

32. Combination of Ibrutinib Plus Venetoclax with MRD-Driven Duration of Treatment Results in a Higher Rate of MRD Negativity in IGHV Unmutated Than Mutated CLL: Updated Interim Analysis of FLAIR Study

33. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

36. Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia

37. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

38. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

39. The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma

40. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

42. Development of a distributed international patient data registry for hairy cell leukemia.

43. Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia

46. Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior

47. BCL2 Inhibition in Refractory Hairy-Cell Leukemia.

48. TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study.

Catalog

Books, media, physical & digital resources